Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

NYU Langone launches Concussion Center, talks brain injury research

NYU Langone Medical Center in New York City officially launched its Concussion Center on March 19, with an event featuring presentations from a professional athlete and experts on the topic of brain injuries.

Alzheimer’s likely takes more than two decades to develop

A prospective study published in the April issue of The Lancet showed how beta-amyloid burden in the brain relates to the long-term progression of cognitive decline, cerebral atrophy and other indications of Alzheimer’s disease (AD). “Beta-amyloid deposition is slow and protracted, likely to extend for more than two decades,” the authors wrote.

Example of a mammogram showing X-ray images of both the right and left breast and patches of dense breast tissue.

ACR, SBI launch screening mammo offense

A study published March 18 in Annals of Family Medicine that detailed long-term psychosocial harms of false-positive screening mammograms is compromised by methodological irregularities, underplays the harm of a breast cancer diagnosis and does not address existing strategies used to minimize anxiety, according to statements by the American College of Radiology (ACR), the Society of Breast Imaging (SBI) and breast imaging experts.

Amerinet inks three-year deal for Carestream digital imaging systems

Amerinet, a St. Louis-based organization that collaborates with providers to improve performance, has signed a three-year agreement to offer Carestream’s CR and DR digital imaging systems to its 60,000-plus members nationwide.

PET/MR holds promise for a range of diseases

The emergence of PET/MR imaging has been solidly underway for a few years and the combination of the two modalities represents significant improvements to PET alone, namely MR’s excellent soft-tissue contrast and ability to capture not only physiologic but also biochemical and metabolic data. A review in the March issue of The Journal of Nuclear Medicine presents an updated perspective on how PET/MR is moving forward.

Lymph node biopsy for prostate cancer best planned with hybrid imaging

Sentinel lymph node (SLN) biopsies determining primary prostate cancer metastases require diversified imaging techniques due to the location of these lymph nodes buried within the pelvis and elsewhere. As many as 44 percent of SLNs are located outside the pelvic region. Hybrid near-infrared fluorescence and SPECT/CT or PET/MR may provide some advantages before and during surgery, according to a review in the March issue of The Journal of Nuclear Medicine.

Don’t delay: 1/3 of stroke patients have differing baseline, 90-day MRI results

When it comes to MRI scans following stroke, a new study bluntly states “Do it or lose it,” as diagnostic yield is significantly reduced if a scan is not conducted in a timely manner, according to results published in the March issue of Stroke.

Can a false-positive mammo trigger existential crisis?

Women who experience a false-positive screening mammogram incur long-term psychosocial harms, researchers reported March 18 in Annals of Family Medicine. Three years after a false-positive result, women recounted psychosocial consequences at a range between those with normal results and women with a breast cancer diagnosis. 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.